Literature DB >> 17383694

Contribution of AhyR to virulence of Aeromonas hydrophila J-1.

Z X Bi1, Y J Liu, C P Lu.   

Abstract

Aeromonas hydrophila is a broad-host-range pathogen and its pathogenesis is multifactorial. A regulatory mechanism known as quorum sensing has been found to be involved in the regulation of virulence in many bacteria. In A. hydrophila the ahyR gene encodes LuxR-type response regulator. Here we describe the inactivation of the ahyR gene of A. hydrophila J-1 by the insertion of a DNA fragment containing a kanamycin resistance determinant and reintroduced by allelic exchange into the chromosome of A. hydrophila J-1 by means of the suicide plasmid pJP5603. Cytotoxic effects on EPC cells assay and LD(50) determinations in fish demonstrated that the ahyR mutant was highly attenuated relative to the wild-type strain. Compared with the parent strain, some characteristics, such as biochemical characters and outer membrane protein profiles, had changed. Some main virulent determinants could not be detected, including proteases, amylase, Dnase, hemolysin and S layer. This article confirmed the important function of AhyR in the pathogenesis of A. hydrophila J-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383694     DOI: 10.1016/j.rvsc.2007.01.003

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  13 in total

1.  Impact of QseBC system in c-di-GMP-dependent quorum sensing regulatory network in a clinical isolate SSU of Aeromonas hydrophila.

Authors:  Elena V Kozlova; Bijay K Khajanchi; Vsevolod L Popov; Julie Wen; Ashok K Chopra
Journal:  Microb Pathog       Date:  2012-06-01       Impact factor: 3.738

Review 2.  Disruption of bacterial cell-to-cell communication by marine organisms and its relevance to aquaculture.

Authors:  F M I Natrah; Tom Defoirdt; Patrick Sorgeloos; Peter Bossier
Journal:  Mar Biotechnol (NY)       Date:  2011-01-19       Impact factor: 3.619

3.  Orally administered thermostable N-acyl homoserine lactonase from Bacillus sp. strain AI96 attenuates Aeromonas hydrophila infection in zebrafish.

Authors:  Yanan Cao; Suxu He; Zhigang Zhou; Meichao Zhang; Wei Mao; Huitu Zhang; Bin Yao
Journal:  Appl Environ Microbiol       Date:  2012-01-13       Impact factor: 4.792

Review 4.  Zebrafish as a model for zoonotic aquatic pathogens.

Authors:  Hannah M Rowe; Jeffrey H Withey; Melody N Neely
Journal:  Dev Comp Immunol       Date:  2014-03-06       Impact factor: 3.636

5.  Tetrahymena: an alternative model host for evaluating virulence of Aeromonas strains.

Authors:  Mao-Da Pang; Xiao-Qin Lin; Meng Hu; Jing Li; Cheng-Ping Lu; Yong-Jie Liu
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

Review 6.  The Social Life of Aeromonas through Biofilm and Quorum Sensing Systems.

Authors:  Emilie Talagrand-Reboul; Estelle Jumas-Bilak; Brigitte Lamy
Journal:  Front Microbiol       Date:  2017-01-20       Impact factor: 5.640

7.  Molecular characteristics and virulence analysis of eight Aeromonas hydrophila isolates obtained from diseased Amur sturgeon Acipenser schrenckii Brandt, 1869.

Authors:  Yong Zhou; Yuding Fan; Nan Jiang; Wenzhi Liu; Yuheng Shi; Jianqing Zhao; Lingbing Zeng
Journal:  J Vet Med Sci       Date:  2018-01-23       Impact factor: 1.267

8.  Characterization of a novel N-acylhomoserine lactonase, AidP, from Antarctic Planococcus sp.

Authors:  Wah Seng See-Too; Peter Convey; David A Pearce; Kok-Gan Chan
Journal:  Microb Cell Fact       Date:  2018-11-17       Impact factor: 5.328

9.  Morin Protects Channel Catfish From Aeromonas hydrophila Infection by Blocking Aerolysin Activity.

Authors:  Jing Dong; Yongtao Liu; Ning Xu; Qiuhong Yang; Xiaohui Ai
Journal:  Front Microbiol       Date:  2018-11-21       Impact factor: 5.640

10.  Evaluation of the cytotoxic effect and antibacterial, antifungal, and antiviral activities of Hypericum triquetrifolium Turra essential oils from Tunisia.

Authors:  Zyed Rouis; Nabil Abid; Sadok Koudja; Thabet Yangui; Ameur Elaissi; Pier Luigi Cioni; Guido Flamini; Mahjoub Aouni
Journal:  BMC Complement Altern Med       Date:  2013-01-29       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.